|
|
|
Insider
Information: |
Tessmer James F |
Relationship: |
VP, Finance & Accounting |
City: |
The Woodlands |
State: |
TX |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
71,766 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$139,944 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
71,766 |
|
|
Total
Value |
$139,944 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Lexicon Pharmaceuticals Inc |
LXRX |
VP, Finance & Accounting |
2021-03-15 |
71,766 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
38 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & AcctgOfficer |
|
2008-04-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,700 |
|
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Acctg |
|
2009-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
24,100 |
25,800 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2011-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,906 |
25,585 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
30,969 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2013-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,200 |
41,870 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,250 |
51,810 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2014-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,250 |
68,253 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,625 |
91,266 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2016-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,828 |
17,572 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2017-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,939 |
22,885 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2018-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,353 |
27,448 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2019-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,226 |
35,869 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2020-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,396 |
59,764 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2020-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
13,262 |
69,124 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
28,316 |
93,443 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2015-03-02 |
4 |
D |
$0.94 |
$8,499 |
D/D |
(9,041) |
82,225 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2019-08-02 |
4 |
B |
$1.14 |
$11,400 |
D/D |
10,000 |
43,368 |
2.74 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2012-02-28 |
4 |
D |
$1.78 |
$4,092 |
D/D |
(2,299) |
28,670 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2011-02-23 |
4 |
D |
$1.81 |
$3,830 |
D/D |
(2,116) |
23,469 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2010-02-12 |
4 |
D |
$1.91 |
$7,514 |
D/D |
(3,934) |
18,679 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2014-02-28 |
4 |
D |
$1.92 |
$12,695 |
D/D |
(6,612) |
61,641 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2020-04-22 |
4 |
D |
$1.96 |
$7,834 |
D/D |
(3,997) |
65,127 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2013-02-28 |
4 |
D |
$1.98 |
$7,538 |
D/D |
(3,807) |
48,003 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2013-01-31 |
4 |
D |
$2.11 |
$9,094 |
D/D |
(4,310) |
37,560 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
|
2020-02-28 |
4 |
D |
$2.77 |
$10,809 |
D/D |
(3,902) |
55,862 |
0 |
- |
|
38 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|